Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study

By Isik AZ   Caglar GS   Sozen E   Akarsu C   Tuncay G   Ozbıcer T   Vicdan K  

Reproductive BioMedicine Online, Vol. 19, Iss. 4, 2009-10 ,pp. : 472-477

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

High-dose recombinant LH add-back strategy using high-dose GnRH antagonist is an innovative protocol compared with standard GnRH antagonist

By Garcia-Velasco JA   Coelingh Bennink HJT   Epifanio R   Escudero E   Pellicer A   Simón C  

Reproductive BioMedicine Online, Vol. 15, Iss. 3, 2007-09 ,pp. : 280-287

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Case Report: Live births after management of severe OHSS by GnRH antagonist administration in the luteal phase

By Lainas TG   Sfontouris IA   Zorzovilis IZ   Petsas GK   Lainas GT   Alexopoulou E   Kolibianakis EM  

Reproductive BioMedicine Online, Vol. 19, Iss. 6, 2009-12 ,pp. : 789-795

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Luteal phase characteristics following GnRH antagonist or agonist treatment – a comparative study

By Friedler Shevach   Gilboa Sarit   Schachter Morey   Raziel Arieh   Strassburger Devorah   Ron El Raphael  

Reproductive BioMedicine Online, Vol. 12, Iss. 1, 2006-01 ,pp. : 27-32

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Early pregnancy loss is significantly higher after day 3 single embryo transfer than after day 5 single blastocyst transfer in GnRH antagonist stimulated IVF cycles

By Papanikolaou EG   Camus M   Fatemi HM   Tournaye H   Verheyen G   Van Steirteghem Andre   Devroey Paul  

Reproductive BioMedicine Online, Vol. 12, Iss. 1, 2006-01 ,pp. : 60-65

Reproductive Healthcare Ltd

Access to resources Recommend Favorite